Sensulin
sensulin.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Sensulin is a preclinical biopharmaceutical company, that is developing a glucose-responsive insulin for type 1 and type 2 diabetes. Sensulin aims to substantially lower the risk of hypoglycemia, reduce the long-term complications associated with diabetes (eye & kidney disease, etc.), while.
News
Baylor doctor elected National Academy of Inventors fellow
Dr. Ananth Annapragada of Baylor College of Medicine is one of the 175 notable academic inventors named as a fellow of the National Academy of Inventors,...
Read more
Report
7 ways the 'biological century' will transform healthcare
From conquering death to automatic insulin deliveries, we will be able to finetune our biology to a once-unthinkable degree.
Read more
Report
5 predictions for what life will be like in 2030
Driverless cars, smart homes and genetically engineered pets. Here's how tech is about to change your daily life.
Read more
Report
These Americans are changing the world - and they're all under 40
The World Economic Forum released their list of people under 40 who are changing the world, and 20 of them are from the US.
Read more
Report
Having Diabetes Is No Longer Going To Be A Life Sentence
7 ways the 'biological century' will transform healthcare - World Economic Forum Agenda Blog - Article by Mike Moradi, Sensulin CEO
Read more
Report
FundRx's Prescription For Financing Healthcare Startups: Bring In The Doctors
Baylor doctor elected National Academy of Inventors fellow - Baylor College of Medicine press release
Read more
Report